Jun. 17 at 5:55 PM
$IBRX PSS should call for SEC investigation into extremely unusual Short. Everything points to targeted manipulation. The last 6 months has seen a long list of milestones met or exceeded with nothing but a
$HIT storm on the stock price. EAP for Lymphopenia for ‘all tumors’! When has anyone ever heard of a treatment for ‘all patients with solid tumors’. Stock action is more like a MN targeted ‘financial’ execution (in stock terms- down 90%) in the face of good news.
The ‘Why’s’ are important
•Punish PSS
•Steal ImmunityBio at artificially created low price (
$20 buyout looks great when at
$2, but not when stock should be trading at
$30). I just watched this occur w IMGN
•Discourage any other small Biotech from going alone
•Discourage other Billionaires from turning politically neutral
•Force PSS into Shareholder Unfriendly activity to raise capital (reverse split, low stock price dilution, low $ partnerships, etc)
